REPL Latest News, Press Relases and Analysis

All

Press Releases

18 days ago - By: Benzinga - Mentions: VRTX AZN HUM UNH ...

10 Health Care Stocks With Whale Alerts In Today's Session

25 days ago - By: Replimune, Inc.

Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)

25 days ago - By: Replimune, Inc.

Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)

a month ago - By: Replimune, Inc.

Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update

a month ago - By: Stocktwits

What Is Driving Replimune Stock’s 98% Surge Today?

a month ago - By: Replimune, Inc.

Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma

a month ago - By: Replimune, Inc.

Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update

a month ago - By: Benzinga - Mentions: KMB ALPS QURE CLPT ...

Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session

a month ago - By: The Motley Fool - Mentions: BMY

Why Replimune Stock Was Soaring Today

a month ago - By: Replimune, Inc.

Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025

a month ago - By: Bloomberg

Replimune Soars After FDA Accepts Resubmitted Drug Application

a month ago - By: Replimune, Inc.

Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma

a month ago - By: Replimune, Inc.

Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025

2 months ago - By: Bragar Eagel & Squire

REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. is Investigating Replimune Group, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL

2 months ago - By: Faruqi & Faruqi, LLP

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune

2 months ago - By: THE ROSEN LAW FIRM, P. A.

REPL Deadline: REPL Investors with Losses in Excess of $100K Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit Filed by The Rosen Law Firm

2 months ago - By: Bragar Eagel & Squire

REPLIMUNE FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Replimune Group, Inc. Investors to Contact the Firm Regarding Class Action Lawsuit

2 months ago - By: Faruqi & Faruqi LLP

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune

2 months ago - By: The Rosen Law Firm, P.A.

REPL Deadline: Rosen Law Firm Encourages Replimune Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 22 Deadline in Securities Class Action First Filed by the Firm – REPL

2 months ago - By: Hagens Berman Sobol Shapiro LLP

Replimune (REPL) Shares Tank 45% After Company Says No Pathway Identified For Lead Drug RP1, Securities Class Action Pending - Hagens Berman

2 months ago - By: The Motley Fool - Mentions: JPM

Why Replimune Stock Was Tumbling Again Today

2 months ago - By: Bragar Eagel & Squire

REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. and Encourages Investors to Contact the Firm Before September 22nd

REPLIMUNE GROUP INC (REPL) Stock News

REPL Latest News, Press Relases and Analysis